Skip to content
Home/Companies/Pharma/InfoRLife

InfoRLife

Pharma·Switzerland·Active·New
Entry
2026
Hold
New
Status
Active

Who owns InfoRLife?

InfoRLife is currently owned by BC Partners through BC Partners XII (2025 vintage), since 2026.

Hand-verified · updated 2026-08-02

BC Partners
Investor
BC Partners
BC Partners XII · 2025 · Buyout

Key facts

HQSwitzerland
SectorPharma
StatusActive

More from BC Partners XII

Other portfolio companies in the same fund.

Biogaran
Biogaran
Active
PharmaFrance· 2025
Fortidia
Fortidia
Active
LogisticsItaly· 2025
IGS GeboJagema
IGS GeboJagema
Active
MedTechNetherlands· 2025

More BC Partners portfolio companies

From the same investor, across funds.

PetLab Co.
PetLab Co.
Active
ConsumerUK· 2025
CeramTec XI
CeramTec XI
Active
MedTechGermany· 2022
Fedrigoni
Fedrigoni
Active
IndustrialsItaly· 2022
Havea
Havea
Active
ConsumerFrance· 2022
Madison Logic
Madison Logic
Active
SaaSUS· 2022
Davies
Davies
Active
Business ServicesUK· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track InfoRLife

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy InfoRLife?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on InfoRLife.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue